Motley Fool Premium
  1. Stocks
    2. /
  2. Renalytix AI plc (LSE: RENX)
    3. /

LSE:RENX (Renalytix AI plc)

About RENX

Renalytix (LSE: RENX) (OTCQB: RNLXY) is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes. Renalytix has received FDA approval and Medicare reimbursement for kidneyintelX.dkd which is now offered commercially in the United States.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Renalytix AI plc (LSE: RENX) Latest News

Cheerful young businesspeople with laptop working in office
Investing Articles

Best British growth shares for July

| The Motley Fool Staff

We asked our freelance writers to share the top growth shares they’d buy in July, which included data firms and…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

Here’s why the Renalytix share price is tanking

| Christopher Ruane

The Renalytix share price has lost almost 90% of its value in one year. Our writer is a shareholder --…

Read more »

Elevated view over city of London skyline
Investing Articles

2 beaten down UK growth shares to buy now with a spare £300

| Christopher Ruane

Our writer highlights a couple of UK growth shares with recent price falls that he would buy for his portfolio…

Read more »

Investing Articles

This UK medtech share has tumbled 60%. Why would I keep buying?

| Christopher Ruane

After this UK medtech share lost three fifths of its value in one year, our writer assesses whether he ought…

Read more »

Investing Articles

What’s going on with the Renalytix share price?

| Christopher Ruane

The Renalytix share price has been falling recently. Our writer considers why and explains what his next move on the…

Read more »

Investing Articles

3 shares to invest in with £3,000

| Christopher Ruane

Christopher Ruane considers how to put £3,000 to work by setting out the investment case for a trio of shares…

Read more »

many happy international football fans watching tv
Investing Articles

Top British stocks for June

| The Motley Fool Staff

We asked our freelance writers to share their top British stocks for June, including Diageo, Glencore, Renalytix AI and Experian.

Read more »

Investing Articles

Two UK growth shares I’m buying

| Christopher Ruane

In a hunt for UK growth shares, Christopher Ruane has identified two companies for his portfolio. Here he explains why…

Read more »

Hand arranging wood block stacking as step stair on paper pink background
Investing Articles

Why has the Renalytix AI share price jumped?

| Christopher Ruane

On Thursday, the Renalytix AI share price grew by double digits. Christopher Ruane explains why and what he'll do on…

Read more »

Investing Articles

£500 to invest? Here’s how I’d look to make a 1,000% return investing in shares

| Andy Ross

Investing in shares can be hugely rewarding. To make big returns Andy Ross looks to smaller, more agile companies.

Read more »

woman sitting in wheelchair at the table and looking at computer monitor while talking on mobile phone and drinking coffee at home
Investing Articles

The Renalytix share price more than doubled in a year: what I’d do now

| Christopher Ruane

The Renalytix share price more than doubled in a year -- I know what I'll do now.

Read more »

Investing Articles

The price of this UK tech share is up over 80% in just the last month. Would I buy?

| Andy Ross

This UK tech share, which provides artificial intelligence diagnostics, has leapt recently in price and there could be potentially a…

Read more »